One cancer drug shortage has ended and at least 14 oncology drugs are in short supply, according to the FDA, the American Society of Health-System Pharmacists and physicians. Azacitidine injections: ...
Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...
These drugs are the latest in a growing list of oncology medications in short supply: Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug. Iobenguane I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results